Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapyArticle Published on 2023-06-012023-06-02 Journal: Pediatric blood & cancer [Category] 두창, 수두, 홍역, [키워드] Humoral immunity leukemia pediatrics vaccination. [DOI] 10.1002/pbc.30321 PMC 바로가기
Revaccination of children with acute lymphoblastic leukemia following completion of chemotherapyArticle Published on 2023-06-012023-06-02 Journal: Pediatric blood & cancer [Category] 두창, 홍역, [키워드] Humoral immunity leukemia pediatrics vaccination. [DOI] 10.1002/pbc.30321 PMC 바로가기
Attenuated humoral response against SARS-CoV-2 mRNA vaccination in allogeneic stem cell transplantation recipientsArticle Published on 2023-02-012023-07-10 Journal: Cancer science [Category] COVID19(2023년), [키워드] Allogeneic stem cell transplantation COVID-19 Humoral immunity mRNA vaccine. SARS-CoV-2 [DOI] 10.1111/cas.15603 PMC 바로가기
Cross-protective humoral immunity to coronaviruses from SARS coronavirus 2-naïve sera of children with Kawasaki diseaseArticle Published on 2023-02-012023-07-10 Journal: Clinical microbiology and infection : the official [Category] COVID19(2023년), [키워드] coronavirus Humoral immunity Kawasaki disease: MIS-C SARS-CoV-2. [DOI] 10.1016/j.cmi.2022.09.018 PMC 바로가기
SARS-CoV-2-specific T cell and humoral immunity in individuals with and without HIV in an African population: a prospective cohort studyArticle Published on 2023-02-012023-07-11 Journal: International Journal of Infectious Diseases [Category] COVID19(2023년), [키워드] HIV Humoral immunity SARS-CoV-2 T cell responses vaccination. [DOI] 10.1016/j.ijid.2022.12.009 PMC 바로가기
Ad5-nCoV booster and Omicron variant breakthrough infection following two doses of inactivated vaccine elicit comparable antibody levels against Omicron variantsArticle Published on 2023-01-012023-07-10 Journal: Journal of medical virology [Category] COVID19(2023년), [키워드] Ad5-nCoV booster Humoral immunity inactivated vaccine booster. Omicron variants breakthrough infection [DOI] 10.1002/jmv.28163 PMC 바로가기
Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression systemArticle Published on 2023-01-012023-07-10 Journal: Journal of medical virology [Category] COVID19(2023년), [키워드] Humoral immunity Newcastle disease virus vector SARS-CoV-2 vaccine severe acute respiratory syndrome coronavirus-2. T-cell immunity [DOI] 10.1002/jmv.28237 PMC 바로가기
SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG ResponseArticle Published on 2022-12-212023-07-10 Journal: Microbiology Spectrum [Category] COVID19(2023년), [키워드] anti-SARS-CoV-2 immunoglobulin COVID-19 COVID-19 mRNA vaccine Humoral immunity immunoglobulin A Immunoglobulin G neutralizing antibodies. SARS-CoV-2 [DOI] 10.1128/spectrum.02716-22 PMC 바로가기
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical TrialRandomized Controlled Trial Published on 2022-12-192023-07-09 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), [키워드] COVID-19 vaccine booster Humoral immunity live virus neutralization. omicron [DOI] 10.1093/cid/ciac345 PMC 바로가기 [Article Type] Randomized Controlled Trial
Humoral responses after inactivated COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infection: A prospective cohort studyArticle Published on 2022-12-012022-11-15 Journal: Journal of medical virology [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome antibody asymptomatic infections benefit blood sample booster dose Clinical severity collected coronavirus coronavirus disease COVID-19 COVID-19 vaccination detectable dose evaluated Evidence first dose humoral humoral immune response Humoral immunity Humoral response inactivated Inactivated COVID-19 vaccine individual individuals infected individuals Infection median mild cases moderate multicenter NAb titer NAbs naïve individual naïve individuals natural infection Neutralizing Neutralizing activity neutralizing antibody omicron pan-immunoglobulins. participant prospective cohort study Protein receive recovered patient SARS-CoV-2 second dose seroconversion rate severity significantly single dose single vaccine the vaccine U/mL vaccination variant [DOI] 10.1002/jmv.28055 PMC 바로가기